Recent NEWS

METABOLON CLOSES ON $5.3M IN SERIES C FUNDING

BIOMARKERS OF PROSTATE CANCER PROGRESSION IDENTIFIED

METABOLON TECHNOLOGY APPLIED TO NOVEL TOXICOLOGY RESEARCH

Upcoming Events

PLANT BIOLOGY 2009
July 18-22

WORLD CONGRESS ON INDUSTRIAL BIOTECHNOLOGY & BIOPROCESSING

July 19-22

What's New

Metabolon is a diagnostic products and services company offering the industry's leading biochemical profiling platform. Our patented platform provides a global analysis of complex biological samples for the discovery of markers and pathways associated with drug action and disease. This differentiated approach enables the identification of biomarkers useful for the development of a wide range of diagnostics and provides insight into complex biochemical processes such as drug action, toxicology and bioprocess optimization.



mVision

  • Preclinical Toxicology
  • Bioprocessing
  • Consumer Products

mView

  • Academic Research
  • Diabetes
  • Prostate Cancer
  • ALS